Table 3.
In-hospital events in men and women with Takotsubo cardiomyopathy
| In-hospital events | Men (n = 444) | Women (n = 197) | P |
|---|---|---|---|
| Cardiogenic shock | 55 (15) | 16 (11.2) | 0.26 |
| Invasive/noninvasive positive pressure ventilation | 112 (30.2) | 21 (14.6) | 0.001 |
| Mechanical circulatory support (IABP/Impella) | 11 (3) | 4 (2.8) | 0.95 |
| Pharmacologic inotrope/vasopressor support | 62 (17.2) | 12 (8.4) | 0.01 |
| LOS, d | 7 (3–14) | 4 (2–8) | < 0.001 |
| In-hospital death | 36 (8.1) | 2 (1) | < 0.001 |
| Cardiac arrest | 46 (12.4) | 7 (4.9) | 0.01 |
| Combined cardiac arrest/respiratory failure/cardiogenic shock | 141 (36.4) | 31 (20.1) | < 0.001 |
Values are n (%), or median (interquartile range), unless otherwise indicated. Impella pump is from company (Abiomed, Danvers, MA).
IABP, intra-aortic balloon pump; LOS, length of stay.